Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:ESRX

Express Scripts (ESRX) Stock Price, News & Analysis

About Express Scripts Stock (NASDAQ:ESRX)

Key Stats

Today's Range
$92.11
$95.87
50-Day Range
$92.33
$92.33
52-Week Range
$66.93
$101.73
Volume
31.61 million shs
Average Volume
6.64 million shs
Market Capitalization
$52.06 billion
P/E Ratio
13.00
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; Express Scripts SafeGuardRx, a suite of solutions targeting the therapy classes that pose clinical challenges and budgetary threat to its clients; and Inside Rx, a program that provide affordable access to medication for uninsured and underinsured individuals. Its Other Business Operations segment distributes specialty pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides medical benefit management solutions for radiology, cardiology, musculoskeletal disorders, sleep disorders, post-acute care, genetic lab, specialty pharmacy, and medical oncology. The company serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2017, it operated 4 automated dispensing home delivery pharmacies; 1 non-automated dispensing home delivery pharmacy; 7 non-dispensing order processing centers; 5 patient contact centers; 9 specialty home delivery pharmacies; and 34 specialty branch pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in Saint Louis, Missouri.

Receive ESRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Express Scripts and its competitors with MarketBeat's FREE daily newsletter.

ESRX Stock News Headlines

Express Scripts sues FTC over drug pricing report
Unlock the Secret to Easy Wins with Iron Condors
Discover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consistently without needing a large account or watching the market all day. Our free report, The Top 10 Stocks for Iron Condor Trades, reveals exactly how to set up winning trades with minimal downside.
See More Headlines

ESRX Stock Analysis - Frequently Asked Questions

Express Scripts Holding (NASDAQ:ESRX) issued its quarterly earnings data on Wednesday, October, 31st. The company reported $2.43 EPS for the quarter, beating the consensus estimate of $2.42 by $0.01. The firm's revenue was up 3.6% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Express Scripts investors own include Gilead Sciences (GILD), Bank of America (BAC), Cisco Systems (CSCO), General Electric (GE), Intel (INTC), Walt Disney (DIS) and CVS Health (CVS).

Company Calendar

Last Earnings
10/31/2018
Today
9/18/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Stores & Proprietary Stores
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:ESRX
CUSIP
30219G10
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$4.52 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$100.06 billion
Cash Flow
$10.49 per share
Book Value
$32.00 per share

Miscellaneous

Free Float
N/A
Market Cap
$52.06 billion
Optionable
Optionable
Beta
0.88
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Should I Buy Express Scripts Stock? ESRX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, September 8, 2024. Please send any questions or comments about these Express Scripts pros and cons to contact@marketbeat.com.

Express Scripts
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Express Scripts Holding:

  • Express Scripts Holding has shown consistent growth in its PBM segment, offering a wide range of clinical solutions and specialized pharmacy care services, which indicates a strong revenue stream.
  • The company's focus on providing affordable access to medication through programs like Inside Rx can attract a larger customer base, potentially leading to increased market share and profitability.
  • Express Scripts Holding's diverse portfolio of services, including medical benefit management solutions for various healthcare areas, positions it well to capitalize on the evolving healthcare landscape and changing consumer needs.
  • Recent strategic partnerships and acquisitions by Express Scripts Holding have enhanced its market presence and capabilities, signaling a proactive approach to staying competitive in the industry.
  • Considering the current stock price of Express Scripts Holding, which is trading at a reasonable valuation compared to its peers, there may be an opportunity for capital appreciation in the near term.

Express Scripts
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Express Scripts Holding for these reasons:

  • Regulatory changes in the healthcare sector could impact Express Scripts Holding's operations and profitability, leading to uncertainties in future earnings and growth potential.
  • Increased competition in the pharmacy benefit management industry may put pressure on Express Scripts Holding's market position and margins, affecting its ability to sustain growth rates.
  • Concerns about potential disruptions in supply chains or distribution networks, especially during times of economic volatility or global crises, could pose risks to Express Scripts Holding's business continuity and financial performance.
  • Fluctuations in healthcare policies and reimbursement structures could create challenges for Express Scripts Holding in adapting its business model to meet changing regulatory requirements, potentially impacting its bottom line.
  • The evolving landscape of healthcare technologies and digital solutions may require significant investments by Express Scripts Holding to stay competitive, potentially affecting short-term profitability and cash flows.

This page (NASDAQ:ESRX) was last updated on 9/18/2024 by MarketBeat.com Staff
From Our Partners